Education as Prescription for Patients with Type 2 Diabetes Mellitus: Compliance and Efficacy in Clinical Practice

被引:8
|
作者
Kim, Mi Yeon [1 ]
Suh, Sunghwan [1 ]
Jin, Sang-Man [1 ]
Kim, Se Won [1 ]
Bae, Ji Cheol [1 ]
Hur, Kyu Yeon [1 ]
Kim, Sung Hye [2 ]
Rha, Mi Yong [2 ]
Cho, Young Yun [2 ]
Lee, Myung-Shik [1 ]
Lee, Moon Kyu [1 ]
Kim, Kwang-Won [1 ]
Kim, Jae Hyeon [1 ]
机构
[1] Sungkyunkwan Univ Sch Med, Dept Med, Div Endocrinol & Metab, 81 Irwon Ro,Gangnam Gu, Seoul 135710, South Korea
[2] Samsung Med Ctr, Dept Dietet, Seoul, South Korea
关键词
Diabetes mellitus; type; 2; Education; Self care;
D O I
10.4093/dmj.2012.36.6.452
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Diabetes self-management education has an important role in diabetes management. The efficacy of education has been proven in several randomized trials. However, the status of diabetes education programs in real Korean clinical practice has not yet been evaluated in terms of patient compliance with the education prescription. Methods: We retrospectively analyzed clinical and laboratory data from all patients who were ordered to undergo diabetes education during 2009 at Samsung Medical Center, Seoul, Korea (n=2,291). After excluding ineligible subjects, 588 patients were included in the analysis. Results: Among the 588 patients, 433 received education. The overall compliance rate was 73.6%, which was significantly higher in the subjects with a short duration or living in a rural area compared to those with a long duration (85.0% vs. 65.1%, respectively; P<0.001) or living in an urban area (78.2% vs. 70.4%, respectively; P=0.037). The hemoglobin A1c decreased greater in the compliant group (from 7.84 +/- 1.54 at baseline to 6.79 +/- 1.06 at 3 months and 6.97 +/- 1.20 at 12 months after prescription in the compliant group vs. from 7.74 +/- 1.25 to 7.14 +/- 1.02 and 7.24 +/- 1.24 in the non-compliant group; P=0.001). The decrease in hemoglobin A1c was greater in the subjects with a short duration (P=0.032). Conclusion: In our study a large percent of patients refuse to get education despite having a prescription from their physician. This refusal rate was higher in the patients with long-standing diabetes or in urban residence. Furthermore, education was more effective in patients with a short duration of diabetes in clinical practice.
引用
收藏
页码:452 / 459
页数:8
相关论文
共 50 条
  • [1] Efficacy of individualized education in patients with type 2 diabetes mellitus A randomized clinical study protocol
    Huang, Li
    Guo, Hongyan
    Xiu, Lihua
    Wang, Haowen
    MEDICINE, 2020, 99 (50) : E23625
  • [2] TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS TREATED WITH ENDOCRINOLOGISTS IN CLINICAL PRACTICE
    Biryukova, Elena, V
    DIABETES MELLITUS, 2019, 22 (06): : 582 - 591
  • [3] Antithrombotics prescription pattern and clinical outcomes in atrial fibrillation patients with type 2 diabetes mellitus
    Hoo, Y. Y.
    Mazlan-Kepli, W.
    Habizal, N. H.
    Ismail, M. I.
    Wong, Y. P.
    Rosnan, N. H.
    Mohamed, S.
    Abd Ghani, A. R.
    Yusof, H. Mohd
    Ramaiah, A. R. Abdullah
    Selvaraj, K.
    Abd Malek, A. M.
    Ghapar, A. K. Abdul
    EUROPEAN HEART JOURNAL, 2023, 44 : 152 - 152
  • [4] Efficacy of structured education in patients with type 2 diabetes mellitus receiving insulin treatment
    Guo, Xiao Hui
    Ji, Li Nong
    Lu, Ju Ming
    Liu, Jie
    Lou, Qing Qing
    Liu, Jing
    Shen, Li
    Zhang, Ming Xia
    Lv, Xiao Feng
    Gu, Ming Jun
    JOURNAL OF DIABETES, 2014, 6 (04) : 290 - 297
  • [5] Efficacy of berberine in patients with type 2 diabetes mellitus
    Yin, Jun
    Xing, Hulli
    Ye, Hanping
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (05): : 712 - 717
  • [6] Antidiabetic Molecule Efficacy in Patients with Type 2 Diabetes Mellitus-A Real-Life Clinical Practice Study
    Salmen, Teodor
    Rizvi, Ali Abbas
    Rizzo, Manfredi
    Pietrosel, Valeria-Anca
    Bica, Ioana-Cristina
    Diaconu, Cosmina Theodora
    Potcovaru, Claudia Gabriela
    Salmen, Bianca-Margareta
    Coman, Oana Andreia
    Bobirca, Anca
    Stoica, Roxana-Adriana
    Stoian, Anca
    BIOMEDICINES, 2023, 11 (09)
  • [7] SAFETY AND EFFICACY OF LIRAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES AND OBESITY IN CLINICAL PRACTICE
    Dieguez, M.
    Riestra, M.
    Manjon, L.
    Veiguela, B.
    Tuson, C.
    Meana, A.
    Menendez, P.
    Blanco, M. J.
    Casal, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A130 - A130
  • [8] CURRENT CLINICAL PRACTICE CORRESPONDENCE WITH TREATMENT GUIDELINES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Chandran, A.
    Parisi, M.
    Saltiel-Berzin, R.
    Bonafede, M. M.
    VALUE IN HEALTH, 2015, 18 (07) : A621 - A622
  • [9] CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE
    Sapozhnikova, I. E.
    Tarlovskaya, E. I.
    Anufrieva, E. N.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2009, 5 (03) : 8 - 13
  • [10] CLINICAL EFFICACY OF PRAVASTATIN FOR HYPERLIPIDEMIA IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS
    TAWATA, M
    MIWA, I
    TSUCHIYA, K
    OZAWA, M
    SHINDO, H
    WAKASUGI, M
    ONAYA, T
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-1 (06): : 704 - 708